Skip to main content

and
  1. Article

    Open Access

    A new mission for an old anti-cancer drug: harnessing hepatocyte-specific metabolic pathways against liver tumors

    Weiting Liao, Diego F. Calvisi, **n Chen in Signal Transduction and Targeted Therapy (2023)

  2. Article

    Open Access

    Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice

    Liver cancer comprises a group of malignant tumors, among which hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) are the most common. ICC is especially pernicious and associated with po...

    **gxiao Wang, Mingjie Dong, Zhong Xu, **nhua Song, Shanshan Zhang, Yu Qiao in Oncogene (2018)

  3. No Access

    Article

    Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice

    The micronutrient element selenium (Se) has been shown to be effective in reducing the incidence of cancer in animal models and human clinical trials. Selenoproteins and low molecular weight Se compounds were ...

    Sergey V Novoselov, Diego F Calvisi, Vyacheslav M Labunskyy, Valentina M Factor in Oncogene (2005)